ID 7.6.33400 Heidelberg Pharma - Biotech advancing antibody drug conjugates with proprietary toxin technology

Heidelberg Pharma AG is a publicly traded biotech firm based in Germany, specializing in the development of innovative ADCs (Antibody-Drug Conjugates) for cancer treatment.

Heidelberg Pharma advances antibody drug conjugates using its proprietary ATAC technology. The company collaborates with partners for manufacturing and clinical studies, focusing on oncology indications. Experienced teams manage quality and safety while programmes advance through defined stages. The objective is to deliver targeted therapies that broaden options for patients.

Organization

Listed as: Brand page

Brand:

Heidelberg Pharma

Country:

DE

Official page
  • Category: 7. Healthcare & Life Sciences
  • Subcategory: 7.6 Biotech
  • Technology: Antibody drug conjugates. ATAC platform. GMP manufacturing partners. Clinical development.
  • Release Date:
  • Canonical Url: